vs
Privia Health Group, Inc.（PRVA）与天宝（TRMB）财务数据对比。点击上方公司名可切换其他公司
天宝的季度营收约是Privia Health Group, Inc.的1.8倍（$969.8M vs $541.2M），天宝净利率更高（16.1% vs 1.7%，领先14.5%），Privia Health Group, Inc.同比增速更快（17.4% vs -73.7%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 0.9%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
天宝（Trimble Inc.）是1978年成立的美国科技企业，总部位于科罗拉多州威斯敏斯特，于纳斯达克上市，为标普500成分股。公司面向建筑工程、地理空间测绘、交通物流等多个行业，提供软硬件产品及相关技术服务。
PRVA vs TRMB — 直观对比
营收规模更大
TRMB
是对方的1.8倍
$541.2M
营收增速更快
PRVA
高出91.1%
-73.7%
净利率更高
TRMB
高出14.5%
1.7%
两年增速更快
PRVA
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $969.8M |
| 净利润 | $9.2M | $156.6M |
| 毛利率 | — | 72.0% |
| 营业利润率 | 2.1% | 22.3% |
| 净利率 | 1.7% | 16.1% |
| 营收同比 | 17.4% | -73.7% |
| 净利润同比 | 108.0% | 73.6% |
| 每股收益（稀释后） | $0.08 | $0.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVATRMB
| Q4 25 | $541.2M | $901.2M | ||
| Q3 25 | $580.4M | $875.7M | ||
| Q2 25 | $521.2M | $840.6M | ||
| Q1 25 | $480.1M | $983.4M | ||
| Q4 24 | $460.9M | — | ||
| Q3 24 | $437.9M | $875.8M | ||
| Q2 24 | $422.3M | $870.8M | ||
| Q1 24 | $415.2M | $953.3M |
净利润PRVATRMB
| Q4 25 | $9.2M | $111.5M | ||
| Q3 25 | $6.9M | $89.2M | ||
| Q2 25 | $2.7M | $66.7M | ||
| Q1 25 | $4.2M | $90.2M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $3.5M | $40.6M | ||
| Q2 24 | $3.5M | $1.3B | ||
| Q1 24 | $3.0M | $57.2M |
毛利率PRVATRMB
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 68.3% | ||
| Q2 25 | — | 66.7% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 62.7% | ||
| Q1 24 | — | 62.3% |
营业利润率PRVATRMB
| Q4 25 | 2.1% | 16.7% | ||
| Q3 25 | 2.5% | 14.6% | ||
| Q2 25 | 0.6% | 11.6% | ||
| Q1 25 | 1.1% | 17.6% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.3% | 13.3% | ||
| Q2 24 | 1.2% | 7.1% | ||
| Q1 24 | 0.2% | 11.5% |
净利率PRVATRMB
| Q4 25 | 1.7% | 12.4% | ||
| Q3 25 | 1.2% | 10.2% | ||
| Q2 25 | 0.5% | 7.9% | ||
| Q1 25 | 0.9% | 9.2% | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.8% | 4.6% | ||
| Q2 24 | 0.8% | 151.2% | ||
| Q1 24 | 0.7% | 6.0% |
每股收益（稀释后）PRVATRMB
| Q4 25 | $0.08 | $0.46 | ||
| Q3 25 | $0.05 | $0.37 | ||
| Q2 25 | $0.02 | $0.27 | ||
| Q1 25 | $0.03 | $0.36 | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.03 | $0.16 | ||
| Q2 24 | $0.03 | $5.34 | ||
| Q1 24 | $0.02 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $253.4M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $737.2M | $5.8B |
| 总资产 | $1.4B | $9.3B |
| 负债/权益比越低杠杆越低 | — | 0.24× |
8季度趋势，按日历期对齐
现金及短期投资PRVATRMB
| Q4 25 | $479.7M | $232.7M | ||
| Q3 25 | $441.4M | $265.9M | ||
| Q2 25 | $390.1M | $290.0M | ||
| Q1 25 | $469.3M | $738.8M | ||
| Q4 24 | $491.1M | — | ||
| Q3 24 | $422.0M | $1.0B | ||
| Q2 24 | $387.4M | $944.1M | ||
| Q1 24 | $351.1M | $255.1M |
总债务PRVATRMB
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PRVATRMB
| Q4 25 | $737.2M | $5.8B | ||
| Q3 25 | $709.1M | $5.7B | ||
| Q2 25 | $682.9M | $5.4B | ||
| Q1 25 | $659.4M | $5.7B | ||
| Q4 24 | $635.2M | — | ||
| Q3 24 | $614.9M | $5.9B | ||
| Q2 24 | $595.4M | $5.6B | ||
| Q1 24 | $576.8M | $4.3B |
总资产PRVATRMB
| Q4 25 | $1.4B | $9.0B | ||
| Q3 25 | $1.4B | $9.1B | ||
| Q2 25 | $1.3B | $8.9B | ||
| Q1 25 | $1.2B | $9.5B | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $9.9B | ||
| Q2 24 | $1.1B | $9.6B | ||
| Q1 24 | $1.0B | $9.3B |
负债/权益比PRVATRMB
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $386.2M |
| 自由现金流经营现金流 - 资本支出 | — | $360.9M |
| 自由现金流率自由现金流/营收 | — | 37.2% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 13.93× | 2.47× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRVATRMB
| Q4 25 | $127.5M | — | ||
| Q3 25 | $52.0M | $123.8M | ||
| Q2 25 | $8.0M | $155.6M | ||
| Q1 25 | $-24.1M | $115.1M | ||
| Q4 24 | $74.8M | — | ||
| Q3 24 | $33.2M | $94.9M | ||
| Q2 24 | $34.5M | $87.6M | ||
| Q1 24 | $-33.1M | $233.8M |
自由现金流PRVATRMB
| Q4 25 | — | — | ||
| Q3 25 | — | $116.6M | ||
| Q2 25 | — | $149.0M | ||
| Q1 25 | — | $109.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $88.5M | ||
| Q2 24 | — | $73.3M | ||
| Q1 24 | — | $227.0M |
自由现金流率PRVATRMB
| Q4 25 | — | — | ||
| Q3 25 | — | 13.3% | ||
| Q2 25 | — | 17.7% | ||
| Q1 25 | — | 11.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 23.8% |
资本支出强度PRVATRMB
| Q4 25 | — | — | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
现金转化率PRVATRMB
| Q4 25 | 13.93× | — | ||
| Q3 25 | 7.58× | 1.39× | ||
| Q2 25 | 2.97× | 2.33× | ||
| Q1 25 | -5.70× | 1.28× | ||
| Q4 24 | 17.00× | — | ||
| Q3 24 | 9.38× | 2.34× | ||
| Q2 24 | 9.94× | 0.07× | ||
| Q1 24 | -11.10× | 4.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
TRMB
| Subscription and services | $701.5M | 72% |
| Product | $268.3M | 28% |
